IN-CLASS TRANSITION (ICT) from PARENTERAL BORTEZOMIB (V) to ORAL IXAZOMIB in NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): SUBGROUP ANALYSIS of US MM-6 by RACE/ETHNICITY, RENAL FUNCTION, and AREA INCOME

Category Primary study
Conference30th Congress of theEuropean Hematology Association Annual Congress, EHA2025
Year 2025
This article has no abstract
Epistemonikos ID: 85b0963f2ffdde17fc0dd981dc62444d0713a4ff
First added on: Nov 15, 2025